Statistics

Total Visits

Views
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years63

Select a period of time:

Number of views in the range

Views
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years36

Views

Views
March 202516
April 202513
May 20251
June 20250
July 20251
August 20251
September 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Hong Kong12
United States5
Egypt1
Spain1
Peru1
 

Top cities views

Views
Hong Kong12
Dallas4
Lima1
Tanta1